Carl Zeiss Meditec Remains on Growth Course

Revenues increased by 17.1 percent over previous year

06-May-2011 - Germany

Carl Zeiss Meditec is continuing its successful path in the 2010/11 fiscal year and has increased both revenues and earnings. All three strategic business units (SBU) and reporting regions have contributed to this positive trend.

"After the first half of our fiscal year, we remain optimistic and expect revenues between 720 and 750 million euros for the entire year," states Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG.

The half-year result for Japan is particularly positive: despite the recent natural disasters, the company also showed continued stable development in this region. "I would like to extend a special thanks to the employees there. Without their extreme efforts, this would hardly have been possible," adds Dr. Monz.

Overview of the key figures

In the first half of the current fiscal year, Carl Zeiss Meditec generated consolidated revenues of 376.0 million euros (last year: 321.1 million). This corresponds to an increase of 17.1 percent over the previous year. With double-digit revenue growth, all three strategic business units contributed to this positive trend. At 20.6 percent revenue growth, the Microsurgery SBU is the most successful business unit. Ophthalmic Systems generated revenue growth of 15.9 percent and Surgical Ophthalmology 10.2 percent.

All reporting regions of Carl Zeiss Meditec contributed to revenue growth. Despite the recent events in Japan, the Asia-Pacific region generated the most stable and strongest growth at 28.0 percent, followed by the Americas at 16.4 percent and EMEA at 9.1 percent.

Earnings before interest and taxes (EBIT) climbed to 51.3 million euros (last year: 39.3 million). The EBIT margin improved from 12.2 to 13.6 percent in the first half of 2010/11.

"We are very satisfied with the results of the first half year, and we are definitely on the right track." says Dr. Monz. "We are striving for sustained growth in the individual markets, intend to bring additional customer-oriented innovations to the market, to expand into new markets and to continue impressing our customers with excellent services," adds Dr. Monz.

https://www.bionity.com/en/news/132301/carl-zeiss-meditec-remains-on-growth-course.html